147 related articles for article (PubMed ID: 12951637)
1. A pitfall of metaiodobenzylguanidine scan: paraganglioma in close proximity to adrenocortical adenoma.
Kekäläinen P; Alhava E; Vanninen E; Niskanen L
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):294-7. PubMed ID: 12951637
[TBL] [Abstract][Full Text] [Related]
2. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.
Letizia C; De Toma G; Massa R; Corsi A; Caliumi C; Subioli S; D'Erasmo E
J Endocrinol Invest; 1998 Dec; 21(11):779-83. PubMed ID: 9972680
[TBL] [Abstract][Full Text] [Related]
3. Pheochromocytoma associated with adrenocortical tumor in the same gland. Two case reports and literature review.
Cotesta D; Petramala L; Serra V; Giustini S; Divona L; Calvieri S; De Toma G; Ciardi A; Corsi A; Massa R; Reale MG; Letizia C
Minerva Endocrinol; 2006 Jun; 31(2):183-9. PubMed ID: 16682942
[TBL] [Abstract][Full Text] [Related]
4. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review.
Sone H; Okuda Y; Nakamura Y; Ishikawa N; Yamaoka T; Kawakami Y; Odawara M; Matsushima T; Kawai K; Yamashita K
Horm Res; 1996; 46(3):138-42. PubMed ID: 8894669
[TBL] [Abstract][Full Text] [Related]
5. False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.
Rainis T; Ben-Haim S; Dickstein G
J Clin Endocrinol Metab; 2000 Jan; 85(1):5-7. PubMed ID: 10634355
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
d'Herbomez M; Gouze V; Huglo D; Nocaudie M; Pattou F; Proye C; Wémeau JL; Marchandise X
J Nucl Med; 2001 Jul; 42(7):993-7. PubMed ID: 11438617
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma associated with adrenocortical adenoma: case report and literature review.
Inoue J; Oishi S; Naomi S; Umeda T; Sato T
Endocrinol Jpn; 1986 Feb; 33(1):67-74. PubMed ID: 3720679
[TBL] [Abstract][Full Text] [Related]
8. [A case of adrenal pheochromocytoma with contralateral adrenocortical adenoma].
Yotsuyanagi S; Fuse H; Koshida K; Uchibayashi T; Namiki M
Hinyokika Kiyo; 2001 Feb; 47(2):89-93. PubMed ID: 11280892
[TBL] [Abstract][Full Text] [Related]
9. [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].
Padberg BC; Rordorf T; Suter SL; Pfeiffer D; Wild D; Schröder S
Pathologe; 2007 Jul; 28(4):281-4. PubMed ID: 16673076
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of adrenal tumors with radionuclide imaging.
Beierwaltes WH; Sisson JC; Shapiro B
Spec Top Endocrinol Metab; 1984; 6():1-54. PubMed ID: 6395413
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
[TBL] [Abstract][Full Text] [Related]
12. False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.
Takasu N; Hayashi M; Takara M; Iha T; Kouki T; Ohshiro Y; Ogawa Y
Intern Med; 2007; 46(20):1717-21. PubMed ID: 17938527
[TBL] [Abstract][Full Text] [Related]
13. [Clinical analysis of 17 patients with adrenal "incidentaloma"].
Huang J; Zhou Z; Chao C
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):282-4. PubMed ID: 12016808
[TBL] [Abstract][Full Text] [Related]
14. [Which adrenal incidentalomas are to be operated?].
Chapuis Y; Dousset B; Bonnichon P; Massault PP; Hoeffel C; Louvel A
Ann Chir; 2001 Dec; 126(10):985-91. PubMed ID: 11803636
[TBL] [Abstract][Full Text] [Related]
15. [Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Yokoyama H; Tsuji Y
Hinyokika Kiyo; 1999 Oct; 45(10):677-80. PubMed ID: 10586357
[TBL] [Abstract][Full Text] [Related]
16. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.
Giovanella L; Ceriani L; Balerna M; Keller F; Taborelli M; Marone C; Ferone D
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):84-88. PubMed ID: 17538521
[TBL] [Abstract][Full Text] [Related]
18. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Maurea S; Caracò C; Klain M; Mainolfi C; Salvatore M
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292
[TBL] [Abstract][Full Text] [Related]
19. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
Barzon L; Scaroni C; Sonino N; Fallo F; Gregianin M; Macrì C; Boscaro M
J Clin Endocrinol Metab; 1998 Jan; 83(1):55-62. PubMed ID: 9435416
[TBL] [Abstract][Full Text] [Related]
20. Serum chromogranin-A assay in differential diagnosis of incidentally discovered adrenal masses.
Giovanella L
Anticancer Res; 2005; 25(3A):1547-50. PubMed ID: 16033058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
